Windlas Biotech gets GMP certification for new injectable facility

10 Jan 2025 Evaluate

Windlas Biotech has received Good Manufacturing Practices (GMP) certification for its new State-of-the-Art Injectable facility from the Food Safety & Drugs Administration Authority of Uttarakhand, following the inspection in December 2024. The certification states, that the firm is following the Good Manufacturing Practices as per World Health Organization (WHO) TRS Guidelines.

The state-of-the-art facility has been designed with cutting-edge technology and advanced infrastructure to ensure the efficient and safe production of sterile injectable formulations. Equipped with automated systems, robust quality control mechanisms, and eco-friendly processes, the facility exemplifies its strategic focus on operational excellence and sustainability.

With this new GMP-certified injectable facility, all five of Windlas Biotech Manufacturing plants are complying to this standard and it is well poised to expand its product portfolio offerings in the CDMO space.

Windlas Biotech provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. 

Windlas Biotech Share Price

770.65 -20.30 (-2.57%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×